May 18 2015
MALVERN, Pennsylvania—(BUSINESS WIRE)—Encore Dermatology, Inc. announced today that it has begun to commercialize Hylatopic, Tetrix, and BenzEFoam, three highly regarded and established US topical dermatology products acquired from Valeant Pharmaceuticals North America, LLC and certain of its affiliates.
Encore Dermatology, Inc. is a privately held company headquartered in Malvern, Pennsylvania. Encore Dermatology is committed to delivering innovative prescription therapies and medical devices to dermatologists focusing on customer service and improving the quality-of-life of patients. Encore brings together the former leadership team of Precision Dermatology which was sold to Valeant in 2014. William Crouse is Chairman; Bob Moccia - President and CEO; Rick Havens - Executive Vice President, Sales and Marketing; Boris Meyerson, Ph.D. - Executive Vice President, Business Operations; Kent Taylor - Vice President, Marketing; and Tim Waite - Vice President, Sales. Additionally, Charles W. Stiefel, the former Chairman and CEO of Stiefel Laboratories, has agreed to join the board of directors of Encore. Bob Moccia states: “We are very excited about this new opportunity to launch a company which understands what dermatologists have always told us: they want effective and safe products and services from companies and people they know and trust.” Encore will have a wide range of medical dermatology products, treating a number of topical disease states such as acne and atopic dermatitis. Encore Dermatology is rapidly expanding through acquisitions, in-licensing, and co-marketing opportunities.
About Encore Dermatology, Inc.
Headquartered in Malvern, Pennsylvania, Encore Dermatology is a privately held fully-integrated specialty dermatology company with a mission committed to delivering innovative prescription therapies and medical devices to dermatologists focusing on customer service and improving the quality-of-life of patients. In addition to the founders, principal investors will be Essex Woodlands, 1315 Capital and Longitude Capital. For additional information, please visit www.encorederm.com.
Encore Dermatology, Inc.
Kent Taylor, (610) 251-6960